A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation

Journal of Theoretical Biology

Volumn 242, Issue 1, 2006, Pages 220-236

  Reynolds, Angela ^a   Rubin, Jonathan ^a   Clermont, Gilles ^a,b,c   Day, Judy ^a   Vodovotz, Yoram ^a,b,c   Bard Ermentrout, G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CIRM (Center for Inflammation and Regenerative Modeling)   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anti inflammatory cytokines; Bifurcation analysis; Immunology; Mathematical modeling; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE;

HOMEOSTASIS; INFECTIOUS DISEASE; NUMERICAL MODEL;

ARTICLE; CORRELATION ANALYSIS; HOMEOSTASIS; IMMUNITY; IMMUNOMODULATION; INFECTION; INFLAMMATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ACUTE DISEASE; ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNITY, NATURAL; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, IMMUNOLOGICAL; PHAGOCYTES;

HARNESS;

EID: 33747106908     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2006.02.016     Document Type: Article

References (38)

1. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., and Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192 (2000) 565-570
2. Annane D. Corticosteroids for septic shock. Crit. Care Med. 29 (2001) 117-120
3. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., Capellier G., Cohen Y., Azoulay E., Troche G., Chaumet-Riffaut P., and Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
4. Bacon G.E., Kenny F.M., Murdaugh H.V., and Richards C. Prolonged serum half-life of cortisol in renal failure. Johns Hopkins Med. J. 132 (1973) 127-131
5. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., and Fisher Jr. C.J. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
6. Bocci V. Interleukins. Clinical pharmacokinetics and practical implications. Clin. Pharmacokinet. 21 (1991) 274-284
7. Branwood A., Noble K., and Schindhelm K. Phagocytosis of carbon particles by macrophages in vitro. Biomaterials 19 (1992) 646-648
8. Chow C.C., Clermont G., Kumar R., Lagoa C., Tawadrous Z., Gallo D., Betten B., Bartels J., Constantine G., Fink M.P., Billiar T.R., and Vodovotz Y. The acute inflammatory response in diverse shock states. Shock 24 (2005) 74-84
9. Coxon A., Tang T., and Mayadas T.N. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190 (1999) 923-934
10. Cross A.S., and Opal S.M. A new paradigm for the treatment of sepsis: is it time to consider combination therapy?. Ann. Intern. Med. 138 (2003) 502-505
11. D'Andrea A., ste-Amezaga M., Valiante N.M., Ma X., Kubin M., and Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178 (1993) 1041-1048
12. Day, J., Rubin, J., Vodovotz, Y., Chow, C.C., Reynolds, A., Clermont, G., 2006. A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration. J. Theor. Biol., in press.
13. de Waal M.R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
14. Ermentrout G.B. Simulating, Analyzing, and Animating Dynamical Systems: A Guide to XPPAUT for Researchers and Students. first ed (2002), Society for Industrial & Applied Mathematics, Philadelphia
15. Fuchs A.C., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Radwanski E., Affrime M.B., Cutler D.L., Grint P.C., and Dinarello C.A. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J. Clin. Immunol. 16 (1996) 291-303
16. Goris R.J., te Boekhorst T.P., Nuytinck J.K., and Gimbrere J.S. Multiple-organ failure. Generalized autodestructive inflammation?. Arch. Surg. 120 (1985) 1109-1115
17. Huhn R.D., Radwanski E., Gallo J., Affrime M.B., Sabo R., Gonyo G., Monge A., and Cutler D.L. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers. Clin. Pharmacol. Ther. 62 (1997) 171-180 10.1016/S0009-9236(97)90065-5
18. Isler P., de Rochemonteix B.G., Songeon F., Boehringer N., and Nicod L.P. Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. Am. J. Respir. Cell Mol. Biol. 20 (1999) 270-278
19. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
20. Janeway Jr. C.A., Travers P., Walport M., and Shlomchik M. Immunobiology: The Immune System in Health and Disease. fifth ed (2001), Garland Publishing, New York
21. Joyce D.E., and Grinnell B.W. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit. Care Med. 30 (2002) S288-S293
22. Kumar R., Clermont G., Vodovotz Y., and Chow C.C. The dynamics of acute inflammation. J. Theor. Biol. 230 (2004) 145-155
23. Marshall J.C. Clinical trials of mediator-directed therapy in sepsis: what have we learned?. Intensive Care Med. 26 Suppl. 1 (2000) 75-83 10.1007/s001340051122
24. Marshall J.C. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat. Rev. Drug Discov. 2 (2003) 391-405 10.1038/nrd1084
25. Nick J.A., Coldren C.D., Geraci M.W., Poch K.R., Fouty B.W., O'Brien J., Gruber M., Zarini S., Murphy R.C., Kuhn K., Richter D., Kast K.R., and Abraham E. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104 13 (2004) 3878-3885 10.1182/blood-2004-06-2140
26. Ochsenbein A.F., and Zinkernagel R.M. Natural antibodies and complement link innate and acquired immunity. Immunol. Today, 21 (2000) 624-630 10.1016/S0167-5699(00)01754-0
27. Paulsen F., Pufe T., Conradi L., Varoga D., Tsokos M., Papendieck J., and Petersen W. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J. Pathol. 198 (2002) 369-377
28. Raj P.A., and Dentino A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206 (2002) 9-18 10.1016/S0378-1097(01)00496-7
29. Schumer W. Steroids in the treatment of clinical septic shock. Ann. Surg. 184 (1976) 333-341
30. In: Spector W.S. (Ed). Handbook of Biological Data (1956), W.B. Saunders Company, London
31. Sprung C.L., Caralis P.V., Marcial E.H., Pierce M., Gelbard M.A., Long W.M., Duncan R.C., Tendler M.D., and Karpf M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N. Engl. J. Med. 311 (1984) 1137-1143
32. Strogatz S.H. Nonlinear Dynamics and Chaos: With Application to Physics, Biology, Chemistry, and Engineering (1994), Westview Press, Cambridge
33. Stvrtinova V., Jakubovsky J., and Hulin I. The acute phase reactants. Inflammation and Fever (1995), Academic Electronic Press
34. Takala A., Jousela I., Jansson S.E., Olkkola K.T., Takkunen O., Orpana A., Karonen S.L., and Repo H. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin. Sci. (London) 97 (1999) 529-538
35. Todar, K., 2002. Growth of bacterial populations. In: Todar's Online Textbook of Bacteriology. Date Accessed: 10-21-2005. http://www.textbookofbacteriology.net.
36. Tsukaguchi K., de L.B., and Boom W.H. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra. Cell Immunol. 194 (1999) 12-20 10.1006/cimm.1999.1497
37. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., and Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251 10.1126/science.285.5425.248
38. Zouali, M., 2001. Antibodies. In: Encyclopedia of Life Science. Nature Publishing Group. Date Accessed: 8-18-2005. www.els.net.